The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 24, 2007

Filed:

Dec. 18, 2001
Applicants:

Philip J. Barr, Oakland, CA (US);

Helen L. Gibson, Oakland, CA (US);

Philip A. Pemberton, San Mateo, CA (US);

Inventors:

Philip J. Barr, Oakland, CA (US);

Helen L. Gibson, Oakland, CA (US);

Philip A. Pemberton, San Mateo, CA (US);

Assignee:

Arriva Pharmaceuticals, Inc., Alameda, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 1/00 (2006.01); A61K 38/48 (2006.01); A61K 38/00 (2006.01); C07H 21/04 (2006.01); C12N 15/09 (2006.01);
U.S. Cl.
CPC ...
Abstract

Fusion proteins of protease inhibitors are provided, in particular fusion proteins of alpha 1-antitrypsin (AAT) and a second protease inhibitor, such as secretory leukocyte protease inhibitor (SLPI) or tissue inhibitor of metalloproteases (TIMP). Polynucleotides encoding the fusion proteins, vectors comprising such polynucleotides, and host cells containing such vectors are also provided. Methods of making the fusion proteins of the invention are also provide, as well as methods of using the fusion proteins, for example to inhibit protease activity in a biological sample or in the treatment of an individual suffering from, or at risk for, a disease or disorder involving unwanted protease activity.


Find Patent Forward Citations

Loading…